CNC Centene Corporation Common Stock
$65,06
Precio · Ago 19, 2026
Fundamentales a fecha de Jul 28, 2026
Rango 52S
$28–$69
90% of range
Calificación del Analista
HOLD
27 analysts
Precio Objetivo
$72
+10% upside
P/E (TTM)
-6.1
ROE
-28.8%
Margen de Beneficio Neto
-3.4%
Acerca de Centene Corporation Common Stock Descripción general de la empresa de Wikipedia
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500.
Leer más
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500.
History
Centene was founded by Elizabeth Brinn as Managed Health Services in Milwaukee, Wisconsin, in 1984. After the death of Brinn, the non-profit organization was sold to investors. The proceeds went to the Betty Brinn Foundation, which became a major shareholder in Centene. In 1996, Michael Neidorff joined the company as chief executive.
Centene went public in December 2001. In 2006, the firm acquired US Script, a pharmacy benefits manager. The company later merged US Script with subsidiaries to form its Envolve divisions. In 2011, the firm formed Centurion, a provider of correctional health care services, as a joint venture with MHM Services. In 2018, it acquired MHM Services, including its stake in Centurion. Centene began offering state-run Medicaid programs through Affordable Care Act exchanges in 2014.
In July 2015, Centene announced it would acquire Health Net and Trillium Community Health Plan (serving Oregon). In March 2016, it finalized its acquisition. In September 2017, it announced that it would acquire Fidelis Care, a nonprofit insurer in New York, for US$3.75 billion. In March 2019, it announced plans to acquire WellCare for US$17.3 billion. In January 2021, it was announced that it would acquire Magellan Health for $2.2 billion. In January 2022, the acquisition was completed.
In the United Kingdom, Centene began to acquire local healthcare services in 2017. In 2019, Centene, through its subsidiary MH Services, took a 40% stake in Circle Health, as part of a deal which created a national network of over 50 private hospitals. Centene gained full control of Circle Health in July 2021, and sold the business to PureHealth in August 2023.
In early 2021, Operose Health, a UK subsidiary of Centene, took over a group of London practices, AT Medics.
In May 2022, Centene sold off its pharmacy benefit management businesses, Magellan Rx and PANTHERx Rare, for a total of $2.8 billion.
Business segments
The main lines of Centene include:
Medicaid
Arizona Complete Health
Arkansas Total Care
Health Net (California)
Delaware First Health
Sunshine Health (Florida)
Peach State Health Plan (Georgia)
'Ohana Health Plan (Hawaii)
Meridian (Illinois and Michigan)
Managed Health Care Services (Indiana)
Iowa Total Care
Sunflower Health Plan (Kansas)
WellCare of Kentucky
Louisiana Healthcare Connections
Magnolia Health (Mississippi)
Home State Health Plan (Missouri)
Nebraska Total Care
SilverSummit Healthplan (Nevada)
NH Healthy Families (New Hampshire)
Fidelis Care (New Jersey, New York)
Carolina Complete Health (North Carolina)
WellCare of North Carolina
Buckeye Health Plan (Ohio)
Oklahoma Complete Health
Trillium Community Health Plan (Oregon)
PA Health & Wellness (Pennsylvania)
Absolute Total Care (South Carolina)
Superior HealthPlan (Texas)
Coordinated Care (Washington)
MHS Health Wisconsin
ACA health insurance marketplace - Ambetter
Arkansas Health & Wellness
Celtic Insurance Company
WellCare of New Jersey
Medicare
WellCare
Allwell
Correctional healthcare - Centurion
Commercial insurance
QualChoice (Arkansas)
Health Net (California, Oregon)
Behavioral health - Magellan Health
Leaders
In 2020, CEO Michael Neidorff's compensation of nearly $25 million made him the highest-paid healthcare executive in the United States.
In December 2021, Politan Capital Management took a $900 million stake in Centene. Weeks later, Neidorff announced plans to retire within a year. He actually stepped down in March 2022.
He was replaced by Sarah London.
Controversies
In 2014, Fox News alleged that Superior HealthPlan of Texas denied coverage of an infant's surgery for brain cancer at Texas Children's Hospital. Superior HealthPlan is a joint venture of Centene and Community Health Centers Network LP, which provides services for Medicaid recipients. The article reported that Superior HealthPlan had previously paid healthcare claims for the infant at the hospital, although Superior HealthPlan stated that it did not cover procedures at the facility. Three days after the article was published, Superior HealthPlan reversed its decision and covered the surgery.
In January 2018, a class action lawsuit accused Centene's Ambetter marketplace healthcare plans of misleading enrollees about plan benefits. According to the lawsuit, people who bought Centene's plans had difficulty finding medical providers that accepted patients covered under Centene's policies.
In December 2018, Centene was sued by two pension funds alleging that Centene's acquisition of Health Net resulted in damages to Centene and exposed the company to potential liability. The suit also alleged that Centene concealed that Health Net owed approximately $1B in past tax liabilities to California and was under investigation for Medicare fraud at the time of the acquisition.
In 2022, Operose Health had almost 600,000 NHS patients and was the largest supplier of GP services to the NHS. It was accused of putting patients at risk by prioritising profit, specifically by hiring physician associates, because they were cheaper than GPs. At Operose practices the average number of full time equivalent GPs per patients is about half the average in English practices. Sir Sam Everington said he was worried to see physician associates saying they were not receiving the supervision they needed. The practice had a backlog of thousands of medical test results and hospital letters on their computer systems. Operose said 97% of its practices were rated "good" or "outstanding" by the Care Quality Commission.
In April of 2026, Centene Corporation reportedly ended coverage of hormone replacement therapy for transgender patients in its Ambetter Insurance medicare and medicaid plans across 19 states without informing customers.
Settlements
In April 2021, Health Net Federal Services, a subsidiary of Centene, agreed to pay $97M to settle allegations that it had duplicated or inflated claims submitted to the Department of Veterans Affairs.
Between June 2021 and January 2022, Centene agreed to settlements with several states on behalf of their subsidiary, Envolve, a pharmacy benefit manager, including Ohio, Mississippi, Illinois, Arkansas, and New Hampshire to resolve allegations of overpayments to the PBM from the states' Medicaid programs. The settlements have totaled over $191 million.
In December 2021, Centene agreed to pay $27.6M to Kansas to settle allegations that it had failed to disclose discounts and used other strategies to obtain more profit from Kansas' Medicaid program.
In September 2022, Centene will pay more than $14 million to Massachusetts's to resolve claims that it overcharged the state Medicaid program, MassHealth, millions of dollars for pharmacy benefits and services provided by subsidiary companies.
Centene overbilled Florida $67 million in 2021 and proactively notified the state. Their discussions with Agency for Health Care Administration (AHCA) ended in 2024 and Centene agreed to return the $67 million. $10 million of that was sent to Hope Florida Foundation, rather than the state directly.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
CNC Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$65.06
Capitalización Bursátil
$40.69B
P/E (TTM)
-6.1
BPA (TTM)
$-13.53
Ingresos (TTM)
$194.78B
Rendimiento div.
—
ROE
-28.8%
Deuda/Capital
0.9
Rango 52S
$28 – $69
CNC Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$194.78B
2016-12-31
→
2025-12-31
BPA
$-13.53
2016-12-31
→
2025-12-31
Flujo de caja libre
$4.32B
2016-12-31
→
2025-12-31
Márgenes
-3.4%
2023-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
CNC
Mediana de Pares
P/E (TTM)
-6.1
35.0
P/S (TTM) (P/V (TTM))
0.2
0.9
P/B (P/C)
2.0
3.5
EV / EBITDA
-5.0
—
Price / FCF (Precio / FCF)
9.4
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
CNC
Mediana de Pares
Gross Margin (Margen Bruto)
7.3%
12.9%
Operating Margin (Margen Operativo)
-3.9%
—
Net Profit Margin (Margen de Beneficio Neto)
-3.4%
0.89%
ROA
-8.4%
3.5%
ROE
-28.8%
10.1%
ROIC
-20.2%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
CNC
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
0.9
—
Current Ratio (Ratio corriente)
1.1
1.6
Quick Ratio (Ratio Rápido)
0.6
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
CNC
Mediana de Pares
Revenue YoY (Ingresos interanuales)
19.4%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
10.4%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
11.9%
—
EPS YoY (EPS interanual)
27.5%
—
Net Income YoY (Beneficio Neto interanual)
22.3%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
CNC
Mediana de Pares
CNC Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
27 analistas
- Compra fuerte 4 14,8%
- Compra 7 25,9%
- Mantener 15 55,6%
- Venta 1 3,7%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
18 analistas · 2026-08-13
Mediana
$70.50
Ahora
$65.06
Mín
$56.00
Máx
$85.00
Objetivo mediano
$70.50
+8,4%
Objetivo medio
$71.67
+10,2%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.44%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $2.51 | $1.10 | 1.4% |
| 31 de marzo de 2026 | $3.37 | $2.15 | 1.2% |
| 31 de diciembre de 2025 | $-1.19 | $-1.24 | 0.05% |
| 30 de septiembre de 2025 | $0.50 | $-0.14 | 0.64% |
| 30 de junio de 2025 | $-0.16 | $0.87 | -1.0% |
| 31 de marzo de 2025 | $2.90 | $2.57 | 0.33% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Cost of Revenue | $2.67B | $2.73B | $3.56B | $7.03B | $4.89B | $3.30B | $2.46B | $2.39B | $1.85B | $1.86B | $1.62B | $1.28B | |
| Gross Profit | $14.21B | $17.07B | $17.64B | $16.92B | $14.49B | · | · | · | · | · | · | · | |
| SG&A Expense | $12.90B | $12.40B | $12.56B | $11.59B | $9.60B | $9.38B | $6.53B | $6.04B | $4.45B | $3.67B | $1.80B | $1.30B | |
| Operating Expenses | $202.40B | $159.90B | $151.07B | $143.23B | $124.20B | $108.03B | $72.86B | $58.66B | $47.18B | $39.34B | $22.05B | $16.10B | |
| Operating Income | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M | |
| Interest Expense | · | · | $725M | $665M | $665M | $728M | $412M | $343M | $255M | $217M | $43M | $35M | |
| Other Non-op | $895M | $1.08B | $668M | $644M | · | · | · | · | · | · | · | · | |
| Pretax Income | $-6.73B | $4.26B | $3.60B | $1.96B | $1.81B | $2.77B | $1.78B | $1.37B | $1.13B | $1.16B | $697M | $457M | |
| Income Tax | $-51M | $963M | $899M | $760M | $477M | $979M | $473M | $474M | $326M | $599M | $339M | $196M | |
| Net Income | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| EPS (Basic) | $-13.53 | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 | $3.19 | $2.31 | $2.40 | $1.76 | $2.98 | $2.33 | |
| EPS (Diluted) | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 | $3.12 | $3.14 | $2.26 | $2.34 | $1.71 | $2.88 | $2.25 | |
| Shares (Basic) | 493,116,000 | 521,790,000 | 543,319,000 | 575,191,000 | 582,832,000 | 570,722,000 | 413,487,000 | 390,248,000 | 344,853,000 | 319,135,000 | 119,101,000 | 116,345,764 | |
| Shares (Diluted) | 493,116,000 | 523,744,000 | 545,704,000 | 582,040,000 | 590,516,000 | 579,135,000 | 420,409,000 | 398,506,000 | 353,404,000 | 327,951,000 | 123,066,000 | 120,360,212 | |
| EBITDA | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M |
Balance general 26
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.89B | $14.06B | $17.19B | $12.07B | $13.12B | $10.80B | $12.12B | $5.34B | $4.07B | $3.93B | $1.76B | $1.61B | |
| Short-term Investments | $2.43B | $2.62B | $2.46B | $2.32B | $1.54B | $1.58B | $863M | $722M | $531M | $505M | $176M | $177M | |
| Other Current Assets | $1.95B | $1.60B | $5.57B | $2.46B | $1.60B | $1.32B | $1.09B | $784M | $687M | $715M | $390M | $252M | |
| Current Assets | $40.37B | $38.00B | $40.76B | $30.13B | $28.50B | $23.39B | $20.32B | $12.00B | $8.70B | $8.37B | $3.60B | $2.95B | |
| PP&E (Net) | $2.04B | $2.07B | $2.02B | $2.43B | $3.39B | $2.77B | $2.12B | $1.71B | $1.10B | $797M | $518M | $445M | |
| PP&E (Gross) | $4.27B | $4.87B | $4.42B | $4.50B | $5.29B | $4.25B | $3.22B | $2.51B | $1.69B | $1.24B | $869M | $733M | |
| Accum. Depreciation | $2.23B | $2.80B | $2.40B | $2.07B | $1.90B | $1.48B | $1.10B | $800M | $590M | $442M | $351M | $288M | |
| Goodwill | $10.84B | $17.56B | $17.56B | $18.81B | $19.77B | $18.65B | $6.86B | $7.01B | $4.75B | $4.71B | $842M | $754M | |
| Intangibles | $4.53B | $5.41B | $6.10B | $6.91B | $7.82B | $8.39B | $2.06B | $2.24B | $1.40B | $1.54B | $155M | $120M | |
| Other Non-current Assets | $528M | $593M | $535M | $2.69B | $3.78B | $1.60B | $1.25B | $527M | $454M | $95M | $177M | $174M | |
| Total Assets | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Accounts Payable | $13.80B | $13.17B | $16.42B | $9.53B | $8.49B | $7.07B | $4.16B | $4.05B | $4.17B | $3.76B | $976M | $768M | |
| Current Liabilities | $36.72B | $34.26B | $36.72B | $28.46B | $25.77B | $21.59B | $12.93B | $11.97B | $9.33B | $8.62B | $3.63B | $2.90B | |
| Capital Leases | $615M | $738M | $880M | $3.13B | $3.62B | $1.33B | $622M | · | · | · | · | · | |
| Deferred Tax | $833M | $684M | $641M | $615M | $1.41B | $1.53B | $189M | · | · | · | · | · | |
| Other Non-current Liabilities | $1.79B | $2.57B | $3.62B | $5.62B | $5.61B | $2.96B | $1.54B | $1.26B | $952M | $869M | $170M | $159M | |
| Total Liabilities | $56.69B | $55.94B | $58.69B | $52.63B | $51.35B | $42.76B | $28.30B | $19.88B | $14.98B | $14.14B | $5.01B | $3.93B | |
| Long-term Debt | $17.49B | $18.64B | $17.96B | $18.18B | $19.03B | $16.88B | $13.86B | $6.85B | $4.83B | $4.78B | $1.22B | $878M | |
| Total Debt | $17.40B | $18.53B | $17.83B | $18.02B | $18.84B | $16.78B | $13.73B | $6.69B | $4.70B | $4.66B | $1.22B | $893M | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $8.67B | $15.35B | $12.04B | $9.34B | $8.14B | $6.79B | $4.98B | $3.66B | $2.75B | $1.92B | $1.36B | $1.00B | |
| Treasury Stock | $9.44B | $9.00B | $5.86B | $4.21B | $1.09B | $816M | $214M | $139M | $244M | $179M | $147M | $98M | |
| AOCI | $-58M | $-504M | $-652M | $-1.13B | $77M | $337M | $134M | $-56M | $-3M | $-36M | $-10M | $-1M | |
| Stockholders' Equity | $19.95B | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B | $5.89B | $2.16B | $1.74B | |
| Liabilities + Equity | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Shares Outstanding | 491,757,000 | 620,195,000 | 615,291,000 | 607,847,000 | 602,704,000 | 598,249,000 | 421,508,000 | 417,695,000 | 360,758,000 | 356,268,000 | 253,710,000 | 124,275,000 |
Flujo de Efectivo 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.27B | $1.24B | $1.29B | $1.43B | $1.33B | $1.26B | $643M | $495M | $361M | $278M | $111M | $89M | |
| Stock-based Comp | $204M | $212M | $216M | $234M | $203M | $281M | $177M | $145M | $135M | $148M | $71M | $48M | |
| Deferred Tax | $-60M | $13M | $-78M | $-631M | $-132M | $-51M | $55M | $-129M | $-108M | $92M | $-17M | $-42M | |
| Amort. of Intangibles | $685M | $692M | $718M | $817M | $770M | $719M | $258M | $211M | $156M | $147M | $24M | $16M | |
| Operating Cash Flow | $5.09B | $154M | $8.05B | $6.26B | $4.21B | $5.50B | $1.48B | $1.23B | $1.49B | $1.85B | $658M | $1.22B | |
| CapEx | $767M | $644M | $799M | $1.00B | $910M | $869M | $730M | $675M | $422M | $306M | $150M | $103M | |
| Investing Cash Flow | $472M | $-1.05B | $-1.19B | $-2.92B | $-3.30B | $-6.96B | $-1.53B | $-4.58B | $-1.25B | $-2.47B | $-813M | $-848M | |
| Debt Issued | $750M | $1.30B | $2.33B | $360M | $9.27B | $5.11B | $24.72B | $6.08B | $1.40B | $8.95B | $1.93B | $1.88B | |
| Net Debt Issued | $-1.15B | $678M | $19M | $-1.13B | $1.83B | $1.04B | $6.92B | $1.99B | $47M | $2.87B | $342M | $201M | |
| Stock Issued | $37M | $46M | $44M | $70M | $35M | $28M | $0 | $2.78B | $0 | $0 | · | · | |
| Stock Repurchased | $475M | $3.12B | $1.63B | $3.10B | $297M | $626M | $75M | $71M | $65M | $63M | $53M | $29M | |
| Net Stock Activity | $-438M | $-3.08B | $-1.59B | $-3.03B | $-297M | $-626M | $-75M | $2.71B | $-65M | $-63M | $-53M | $-29M | |
| Financing Cash Flow | $-1.62B | $-2.41B | $-1.66B | $-4.20B | $1.36B | $260M | $6.83B | $4.61B | $-82M | $2.72B | $305M | $198M | |
| Net Change in Cash | $3.94B | $-3.30B | $5.17B | $-868M | $2.26B | $-1.17B | $6.78B | $1.26B | $153M | $2.10B | $150M | $572M | |
| Taxes Paid | $448M | $1.00B | $887M | $1.20B | $678M | $1.19B | $612M | $448M | $496M | $556M | $328M | $237M | |
| Free Cash Flow | $4.32B | $-490M | $7.25B | $5.26B | $3.29B | $4.63B | $753M | $559M | $1.07B | $1.54B | $508M | $1.12B | |
| Levered FCF | · | · | $6.71B | $4.85B | $2.80B | $4.16B | $450M | $335M | $885M | $1.44B | $486M | $1.10B |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.3% | 10.5% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| Net Margin | -3.4% | 2.0% | 1.8% | 0.83% | 1.1% | 1.6% | 1.8% | 1.5% | 1.7% | 1.4% | 1.6% | 1.6% | |
| Pretax Margin | -3.5% | 2.6% | 2.3% | 1.4% | 1.4% | 2.5% | 2.4% | 2.3% | 2.3% | 2.9% | 3.1% | 2.8% | |
| EBITDA Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| ROA | -8.4% | 4.0% | 3.4% | 1.6% | 1.8% | 3.3% | 3.7% | 3.4% | 3.9% | 4.1% | 5.4% | 5.8% | |
| ROE | -28.8% | 12.7% | 10.8% | 4.7% | 5.1% | 9.4% | 11.3% | 10.1% | 13.0% | 14.0% | 18.2% | 18.2% | |
| ROIC | -20.2% | 5.5% | 5.0% | 1.9% | 2.9% | 4.7% | 5.0% | 5.4% | 7.4% | 5.8% | 10.7% | 10.1% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.6 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| Interest Coverage | · | · | 4.0 | 2.0 | 2.7 | 4.2 | 4.3 | 4.3 | 4.7 | 5.8 | 16.4 | 13.3 |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.4 | 2.0 | 1.9 | 1.9 | 1.7 | 2.0 | 2.1 | 2.3 | 2.3 | 2.9 | 3.5 | 3.5 |
Tasas de Crecimiento 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.4% | 5.9% | 6.5% | 14.7% | 13.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 27.5% | 139.1% | -9.2% | -26.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 40.4% | 16.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 22.3% | 124.8% | -10.8% | -25.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 34.9% | 14.3% | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Net Income TTM | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| Market Cap | $20.24B | $30.04B | $39.66B | $45.17B | $48.00B | $34.91B | $26.09B | $23.78B | $8.75B | $4.86B | $3.96B | $3.07B | |
| Enterprise Value | $17.32B | $31.89B | $37.84B | $48.79B | $52.18B | $39.31B | $26.83B | $24.40B | $8.84B | $5.08B | $3.24B | $2.24B | |
| P/E | -3.0 | 9.6 | 15.0 | 39.6 | 36.1 | 19.2 | 20.0 | 25.5 | 21.6 | 16.5 | 11.4 | 11.5 | |
| P/S | 0.1 | 0.2 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.4 | 0.2 | 0.1 | 0.2 | 0.2 | |
| P/B | 1.0 | 1.1 | 1.5 | 1.9 | 1.8 | 1.4 | 2.1 | 2.2 | 1.3 | 0.8 | 1.8 | 1.8 | |
| P / Tangible Book | 4.4 | 8.7 | 18.2 | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 4.0 | 195.1 | 4.9 | 7.2 | 11.4 | 6.3 | 17.6 | 19.3 | 5.9 | 2.6 | 6.0 | 2.5 | |
| P / FCF | 4.7 | -61.3 | 5.5 | 8.6 | 14.6 | 7.5 | 34.7 | 42.5 | 8.2 | 3.1 | 7.8 | 2.7 | |
| EV / EBITDA | -2.3 | 10.0 | 12.9 | 37.0 | 29.2 | 12.8 | 15.1 | 16.7 | 7.4 | 4.0 | 4.6 | 4.8 | |
| EV / FCF | 4.0 | -65.1 | 5.2 | 9.3 | 15.8 | 8.5 | 35.6 | 43.7 | 8.3 | 3.3 | 6.4 | 2.0 | |
| EV / Revenue | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Earnings Yield | -32.9% | 10.4% | 6.7% | 2.5% | 2.8% | 5.2% | 5.0% | 3.9% | 4.6% | 6.0% | 8.8% | 8.7% |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53.58B | $49.94B | $49.73B | $49.69B | $48.74B | $46.62B | $40.80B | $42.02B | $39.84B | $40.41B | $39.46B | $38.04B | $37.61B | $38.89B | $35.56B | $35.87B | |
| Cost of Revenue | $729M | $702M | $680M | $651M | $641M | $698M | $688M | $692M | $680M | $669M | $961M | $856M | $877M | $870M | $1.37B | $1.57B | |
| Gross Profit | $4.62B | $5.65B | $2.56B | $3.35B | $3.02B | $5.29B | $3.80B | $4.01B | $4.53B | $4.74B | $3.74B | $4.63B | $4.61B | $4.65B | $3.91B | $4.04B | |
| SG&A Expense | $3.10B | $3.40B | $3.37B | $3.15B | $3.04B | $3.35B | $3.23B | $3.06B | $2.89B | $3.22B | $3.49B | $3.05B | $3.02B | $3.01B | $3.20B | $2.85B | |
| Operating Expenses | $52.38B | $48.08B | $51.47B | $56.64B | $49.20B | $45.09B | $40.63B | $41.36B | $38.61B | $39.30B | $39.65B | $37.31B | $36.44B | $37.67B | $35.84B | $35.39B | |
| Operating Income | $1.20B | $1.86B | $-1.75B | $-6.95B | $-458M | $1.53B | $175M | $665M | $1.23B | $1.11B | $-194M | $735M | $1.17B | $1.22B | $-282M | $476M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $178M | · | $181M | $181M | $180M | · | $169M | |
| Other Non-op | $288M | $238M | $202M | $280M | $201M | $212M | $172M | $256M | $287M | $367M | · | · | · | · | · | · | |
| Pretax Income | $1.49B | $2.10B | $-1.54B | $-6.67B | $-257M | $1.75B | $347M | $921M | $1.52B | $1.47B | $24M | $768M | $1.42B | $1.39B | $41M | $1.01B | |
| Income Tax | $399M | $560M | $-443M | $-42M | $2M | $432M | $67M | $211M | $370M | $315M | $-15M | $293M | $360M | $261M | $260M | $269M | |
| Net Income | $1.09B | $1.54B | $-1.10B | $-6.63B | $-253M | $1.31B | $283M | $713M | $1.15B | $1.16B | $45M | $469M | $1.06B | $1.13B | $-213M | $738M | |
| EPS (Basic) | $2.21 | $3.13 | $-2.16 | $-13.50 | $-0.51 | $2.64 | $0.63 | $1.37 | $2.16 | $2.17 | $0.12 | $0.87 | $1.93 | $2.05 | $-0.37 | $1.29 | |
| EPS (Diluted) | $2.19 | $3.11 | $-2.15 | $-13.50 | $-0.51 | $2.63 | $0.63 | $1.36 | $2.16 | $2.16 | $0.12 | $0.87 | $1.92 | $2.04 | $-0.35 | $1.27 | |
| Shares (Basic) | 493,819,000 | 492,069,000 | -987,787,000 | 491,141,000 | 493,548,000 | 496,214,000 | -1,064,886,000 | 521,965,000 | 529,602,000 | 535,109,000 | -1,095,927,000 | 539,535,000 | 548,932,000 | 550,779,000 | -1,165,644,000 | 573,961,000 | |
| Shares (Diluted) | 497,637,000 | 495,591,000 | -989,753,000 | 491,141,000 | 493,548,000 | 498,180,000 | -1,068,613,000 | 523,542,000 | 530,755,000 | 538,060,000 | -1,099,719,000 | 541,270,000 | 550,308,000 | 553,845,000 | -1,172,869,000 | 580,607,000 | |
| EBITDA | $1.20B | $1.86B | · | $-6.95B | $-458M | $1.53B | · | $665M | $1.23B | $1.11B | · | $735M | $1.17B | $1.22B | · | $476M |
Balance general 26
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.15B | $21.26B | $17.89B | $17.06B | $14.51B | $14.81B | $14.06B | $14.58B | $17.61B | $17.59B | $17.19B | $18.19B | $17.17B | $15.85B | $12.07B | $14.99B | |
| Short-term Investments | $2.91B | $2.48B | $2.43B | $2.18B | $2.77B | $2.47B | $2.62B | $2.99B | $2.61B | $2.08B | · | $2.24B | $2.21B | $2.13B | · | $2.19B | |
| Other Current Assets | $1.55B | $1.82B | $1.95B | $1.72B | $1.56B | $1.56B | $1.60B | $1.56B | $1.60B | $1.96B | · | $5.47B | $1.88B | $1.81B | · | $2.33B | |
| Current Assets | $46.69B | $44.99B | $40.37B | $44.06B | $40.39B | $41.29B | $38.00B | $37.41B | $38.41B | $38.45B | · | $41.41B | $34.87B | $35.01B | · | $33.27B | |
| PP&E (Net) | $2.13B | $2.09B | $2.04B | $2.16B | $2.12B | $2.04B | $2.07B | $2.04B | $2.04B | $1.99B | · | $2.00B | $2.42B | $2.48B | · | $2.48B | |
| PP&E (Gross) | · | · | $4.27B | · | · | · | $4.87B | · | · | · | · | · | · | · | · | $4.54B | |
| Accum. Depreciation | · | · | $2.23B | · | · | · | $2.80B | · | · | · | · | · | · | · | · | $2.06B | |
| Goodwill | $10.84B | $10.84B | $10.84B | $10.84B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $18.72B | $18.84B | $18.81B | $20.04B | |
| Intangibles | $4.20B | $4.36B | $4.53B | $4.84B | $5.01B | $5.24B | $5.41B | $5.58B | $5.75B | $5.93B | · | $6.28B | $6.52B | $6.73B | · | $7.52B | |
| Other Non-current Assets | $1.37B | $866M | $528M | $593M | $1.11B | $1.24B | $593M | $617M | $1.09B | $823M | · | $560M | $2.87B | $2.78B | · | $2.60B | |
| Total Assets | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Accounts Payable | $17.96B | $16.83B | $13.77B | $16.88B | $13.52B | $13.95B | $13.17B | $13.34B | $12.23B | $12.13B | · | $15.08B | $9.87B | $10.78B | · | $9.99B | |
| Current Liabilities | $40.76B | $40.05B | $36.70B | $40.63B | $36.79B | $37.14B | $34.26B | $34.06B | $32.73B | $32.78B | · | $36.85B | $31.31B | $32.86B | · | $31.33B | |
| Capital Leases | · | · | $615M | · | · | · | $738M | · | · | · | · | $936M | $3.17B | $3.14B | · | $3.04B | |
| Deferred Tax | $756M | $744M | $833M | $810M | $651M | $708M | $684M | $769M | $665M | $734M | · | $577M | $495M | $522M | · | $480M | |
| Other Non-current Liabilities | $2.81B | $2.55B | $1.81B | $2.05B | $3.90B | $2.87B | $2.57B | $2.62B | $4.77B | $4.16B | · | $3.65B | $7.37B | $6.19B | · | $5.68B | |
| Total Liabilities | $60.35B | $59.65B | $56.69B | $61.03B | $58.89B | $59.02B | $55.94B | $54.94B | $55.68B | $55.56B | · | $58.97B | $57.07B | $57.80B | · | $55.57B | |
| Long-term Debt | $16.11B | $16.37B | $17.49B | $17.58B | $17.58B | $18.32B | $18.53B | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Total Debt | $16.11B | $16.37B | · | $17.58B | $17.58B | $18.32B | · | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $11.31B | $10.21B | $8.67B | $9.78B | $16.41B | $16.66B | $15.35B | $15.06B | $14.35B | $13.21B | · | $12.00B | $11.53B | $10.47B | · | $9.55B | |
| Treasury Stock | $9.44B | $9.44B | $9.44B | $9.44B | $9.44B | $9.04B | $9.00B | $8.05B | $6.82B | $6.01B | · | $5.83B | $5.04B | $4.64B | · | $2.56B | |
| AOCI | $-194M | $-171M | $-58M | $-100M | $-231M | $-337M | $-504M | $-226M | $-646M | $-630M | · | $-1.12B | $-998M | $-915M | · | $-1.39B | |
| Stockholders' Equity | $22.56B | $21.43B | $19.95B | $20.95B | $27.41B | $27.92B | $26.41B | $27.31B | $27.35B | $26.96B | · | $25.30B | $25.67B | $25.04B | · | $25.38B | |
| Liabilities + Equity | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Shares Outstanding | 493,987,000 | 493,771,000 | 491,757,000 | 491,414,000 | 491,128,000 | 497,518,000 | 495,907,000 | 510,078,000 | 526,001,000 | 536,383,000 | 615,291,000 | 534,596,000 | 546,003,000 | 551,714,000 | 607,847,000 | 570,091,000 |
Flujo de Efectivo 17
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $300M | $300M | $329M | $317M | $315M | $314M | $314M | $313M | $306M | $308M | $315M | $328M | $304M | $325M | $351M | $292M | |
| Stock-based Comp | $59M | $67M | $58M | $52M | $35M | $59M | $31M | $49M | $62M | $70M | $49M | $50M | $56M | $61M | $54M | $51M | |
| Deferred Tax | $19M | $-53M | $-73M | $129M | $-89M | $-27M | $-1M | $-26M | $-64M | $104M | $-92M | $174M | $-1M | $-159M | $51M | $-265M | |
| Amort. of Intangibles | $161M | $166M | $169M | $170M | $173M | $173M | $173M | $173M | $173M | $173M | $176M | $180M | $179M | $183M | $208M | $211M | |
| Operating Cash Flow | $3.59B | $4.37B | $437M | $1.36B | $1.78B | $1.51B | $-587M | $-978M | $2.17B | $-456M | $217M | $1.02B | $2.55B | $4.27B | $-1.58B | $3.33B | |
| CapEx | $174M | $200M | $213M | $211M | $208M | $135M | $154M | $153M | $186M | $151M | $223M | $136M | $215M | $225M | $233M | $247M | |
| Investing Cash Flow | $-353M | $89M | $660M | $1.24B | $-899M | $-529M | $102M | $-839M | $-1.17B | $852M | $-949M | $435M | $-424M | $-253M | $221M | $3M | |
| Debt Issued | $0 | $0 | $0 | $0 | $0 | $750M | $950M | $0 | $0 | $350M | $165M | $889M | $994M | $287M | $3M | $26M | |
| Net Debt Issued | · | $-1.05B | · | · | · | $-208M | · | · | · | $163M | · | · | · | $287M | · | · | |
| Stock Issued | $8M | $10M | $8M | $11M | $8M | $10M | $9M | $12M | $11M | $14M | $12M | $11M | $21M | $12M | $8M | $24M | |
| Stock Repurchased | $4M | $29M | $2M | $0 | $432M | $41M | $943M | $1.23B | $803M | $151M | $31M | $774M | $405M | $423M | $1.43B | $1.24B | |
| Net Stock Activity | · | $-19M | · | · | · | $-31M | · | · | · | $-137M | · | · | · | $-423M | · | · | |
| Financing Cash Flow | $-259M | $-1.06B | $-187M | $-10M | $-1.17B | $-250M | $-13M | $-1.25B | $-1.17B | $23M | $-201M | $-524M | $-750M | $-183M | $-1.73B | $-1.48B | |
| Net Change in Cash | $2.98B | $3.39B | $910M | $2.59B | $-288M | $731M | $-497M | $-3.06B | $-162M | $425M | $-984M | $958M | $1.36B | $3.83B | $-3.06B | $1.83B | |
| Taxes Paid | $-206M | $-19M | $-92M | $36M | $497M | $7M | $181M | $211M | $538M | $13M | $128M | $167M | $581M | $11M | $750M | $37M | |
| Free Cash Flow | · | $4.17B | · | · | · | $1.38B | · | · | · | $-607M | · | · | · | $4.04B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-747M | · | · | · | $3.90B | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.6% | 11.3% | · | 6.7% | 6.2% | 11.3% | · | 9.5% | 11.4% | 11.7% | · | 12.2% | 12.3% | 11.9% | · | · | |
| Operating Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| Net Margin | 2.0% | 3.1% | · | -13.3% | -0.52% | 2.8% | · | 1.7% | 2.9% | 2.9% | · | 1.2% | 2.8% | 2.9% | · | 2.1% | |
| Pretax Margin | 2.8% | 4.2% | · | -13.4% | -0.53% | 3.8% | · | 2.2% | 3.8% | 3.6% | · | 2.0% | 3.8% | 3.6% | · | 2.8% | |
| EBITDA Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| ROA | 1.3% | 1.8% | · | -8.1% | -0.30% | 1.6% | · | 0.86% | 1.4% | 1.4% | · | 0.57% | 1.3% | 1.4% | · | 0.93% | |
| ROE | 4.4% | 6.2% | · | -27.5% | -0.92% | 4.8% | · | 2.7% | 4.3% | 4.5% | · | 1.8% | 4.1% | 4.3% | · | 2.9% | |
| ROIC | 2.3% | 3.6% | · | -17.9% | -1.0% | 2.5% | · | 1.1% | 2.1% | 1.9% | · | 1.1% | 2.0% | 2.3% | · | 0.80% |
Liquidez y Solvencia 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | |
| Quick Ratio | 0.7 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 6.2 | · | 4.1 | 6.5 | 6.8 | · | 2.8 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 |
Valoración (TTM) 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $201.96B | $195.00B | · | $187.07B | $177.22B | $168.89B | · | $160.31B | $155.89B | $154.95B | · | $150.40B | $148.30B | $147.88B | · | $141.39B | |
| Net Income TTM | $-4.25B | $-4.03B | · | $-4.86B | $2.92B | $4.33B | · | $3.49B | $3.84B | $3.82B | · | $3.40B | $2.75B | $2.54B | · | $2.00B | |
| Market Cap | $31.71B | $16.17B | · | $17.53B | $26.66B | $30.20B | · | $38.40B | $34.87B | $42.10B | · | $36.82B | $36.83B | $34.87B | · | $44.36B | |
| Enterprise Value | $20.76B | $8.80B | · | $15.88B | $26.95B | $31.24B | · | $38.43B | $32.29B | $40.43B | · | $34.39B | $35.45B | $35.21B | · | $45.51B | |
| P/E | -7.4 | -4.0 | · | -3.6 | 9.6 | 7.3 | · | 11.5 | 9.3 | 11.2 | · | 11.3 | 13.7 | 14.2 | · | 22.8 | |
| P/S | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| P/B | 1.4 | 0.8 | · | 0.8 | 1.0 | 1.1 | · | 1.4 | 1.3 | 1.6 | · | 1.5 | 1.4 | 1.4 | · | 1.7 | |
| P / Tangible Book | 4.2 | 2.6 | · | 3.3 | 5.5 | 5.9 | · | 9.2 | 8.6 | 12.1 | · | 25.2 | 84.7 | · | · | · | |
| P / Cash Flow | · | 3.7 | · | · | · | 20.0 | · | · | · | -92.3 | · | · | · | 8.2 | · | · | |
| P / FCF | · | 3.9 | · | · | · | 22.0 | · | · | · | -69.3 | · | · | · | 8.6 | · | · | |
| EV / EBITDA | 17.3 | 4.7 | · | -2.3 | -58.9 | 20.4 | · | 57.8 | 26.3 | 36.6 | · | 46.8 | 30.3 | 28.9 | · | 95.6 | |
| EV / FCF | · | 2.1 | · | · | · | 22.7 | · | · | · | -66.6 | · | · | · | 8.7 | · | · | |
| EV / Revenue | 0.1 | 0.0 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Earnings Yield | -13.6% | -25.3% | · | -28.1% | 10.4% | 13.7% | · | 8.7% | 10.7% | 8.9% | · | 8.9% | 7.3% | 7.1% | · | 4.4% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B |
| Margen Bruto % | 7.3% | 10.5% | 11.5% | — | — |
| Margen Operativo % | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% |
| Beneficio neto | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B |
| EPS Diluido | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 |
| Ratio corriente | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| Ratio Rápido | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $4.32B | $-490M | $7.25B | $5.26B | $3.29B |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 1 125 declarantes · $20.6B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 235 (+120 vs trimestre anterior) | 74 (-55 vs trimestre anterior) | 345 (+50 vs trimestre anterior) | 323 (-35 vs trimestre anterior) | +79.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2 020 581 807 | 31 478 140 | 9,80% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 434 820 070 | 22 352 704 | 6,96% | Acciones |
| STATE STREET CORP | $1 409 957 100 | 21 965 370 | 6,84% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $836 741 748 | 13 035 391 | 4,06% | Acciones |
| AMERIPRISE FINANCIAL INC | $788 928 731 | 12 277 112 | 3,83% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $754 901 345 | 11 765 825 | 3,66% | Acciones |
| HARRIS ASSOCIATES L P | $714 090 642 | 11 124 640 | 3,46% | Acciones |
| NORGES BANK | $491 166 346 | 7 651 758 | 2,38% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $478 360 377 | 7 452 257 | 2,32% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $407 480 559 | 6 348 038 | 1,98% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $366 680 625 | 5 712 426 | 1,78% | Acciones |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $314 595 190 | 4 901 000 | 1,53% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $290 158 057 | 4 520 300 | 1,41% | Opción de compra |
| Assenagon Asset Management S.A. | $238 531 902 | 3 716 029 | 1,16% | Acciones |
| EARNEST PARTNERS LLC | $227 030 787 | 3 536 856 | 1,10% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $219 279 973 | 3 416 108 | 1,06% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $197 821 063 | 3 081 805 | 0,96% | Acciones |
| 8 KNOTS MANAGEMENT, LLC | $193 662 188 | 4 706 250 | 0,94% | Acciones |
| Robeco Institutional Asset Management B.V. | $176 439 634 | 2 748 709 | 0,86% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $170 815 325 | 2 661 089 | 0,83% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $170 810 874 | 2 661 020 | 0,83% | Acciones |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $164 395 918 | 2 561 083 | 0,80% | Acciones |
| JANE STREET GROUP, LLC | $161 149 958 | 2 510 515 | 0,78% | Acciones |
| LYRICAL ASSET MANAGEMENT LP | $157 262 740 | 2 449 957 | 0,76% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $156 896 112 | 2 444 246 | 0,76% | Acciones |
| JANE STREET GROUP, LLC | $150 243 114 | 2 340 600 | 0,73% | Opción de compra |
| RENAISSANCE TECHNOLOGIES LLC | $140 730 926 | 2 192 412 | 0,68% | Acciones |
| Politan Capital Management LP | $137 059 130 | 2 135 210 | 0,66% | Acciones |
| CITADEL ADVISORS LLC | $135 787 526 | 2 115 400 | 0,66% | Opción de compra |
| Qube Research & Technologies Ltd | $131 408 741 | 2 047 184 | 0,64% | Acciones |
| Quantinno Capital Management LP | $126 343 727 | 1 968 277 | 0,61% | Acciones |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $121 065 870 | 1 886 055 | 0,59% | Acciones |
| Scharf Investments, LLC | $105 948 709 | 1 650 542 | 0,51% | Acciones |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $104 240 580 | 1 623 938 | 0,51% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $102 119 807 | 1 590 899 | 0,50% | Acciones |
| Ninety One UK Ltd | $97 040 208 | 1 511 766 | 0,47% | Acciones |
| BlackRock, Inc. | $96 995 070 | 1 511 062 | 0,47% | Acciones |
| IEQ CAPITAL, LLC | $94 667 113 | 1 474 796 | 0,46% | Acciones |
| Long Focus Capital Management, LLC | $93 075 500 | 1 450 000 | 0,45% | Acciones |
| Caisse de depot et placement du Quebec | $90 440 436 | 1 408 949 | 0,44% | Acciones |
| TWO SIGMA ADVISERS, LP | $90 393 876 | 2 196 692 | 0,44% | Acciones |
| Walleye Trading LLC | $89 769 715 | 1 398 500 | 0,44% | Opción de compra |
| Swiss National Bank | $89 039 490 | 1 387 124 | 0,43% | Acciones |
| Maple Rock Capital Partners Inc. | $88 702 813 | 1 381 879 | 0,43% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $88 037 805 | 1 371 519 | 0,43% | Acciones |
| Capital World Investors | $85 968 319 | 1 339 279 | 0,42% | Acciones |
| ROYAL BANK OF CANADA | $83 731 000 | 1 304 424 | 0,41% | Acciones |
| FMR LLC | $82 642 699 | 1 287 470 | 0,40% | Acciones |
| Legal & General Group Plc | $82 580 180 | 1 286 496 | 0,40% | Acciones |
| GOLDMAN SACHS GROUP INC | $81 658 346 | 1 272 135 | 0,40% | Acciones |
| Swedbank AB | $81 278 855 | 1 266 223 | 0,39% | Acciones |
| BANK OF AMERICA CORP /DE/ | $81 231 546 | 1 265 486 | 0,39% | Acciones |
| BANK OF MONTREAL /CAN/ | $75 731 362 | 1 179 800 | 0,37% | Opción de venta |
| Mitsubishi UFJ Asset Management Co., Ltd. | $74 883 027 | 1 166 584 | 0,36% | Acciones |
| Focused Investors LLC | $71 748 372 | 1 117 750 | 0,35% | Acciones |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $69 539 402 | 1 083 337 | 0,34% | Acciones |
| Sumitomo Mitsui Trust Group, Inc. | $69 328 795 | 1 080 056 | 0,34% | Acciones |
| Vanguard Global Advisers, LLC | $67 731 876 | 1 055 178 | 0,33% | Acciones |
| CAXTON ASSOCIATES LP | $66 708 455 | 1 101 163 | 0,32% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $65 768 946 | 1 024 598 | 0,32% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65 005 213 | 1 012 700 | 0,32% | Opción de venta |
| RHUMBLINE ADVISERS | $64 689 517 | 1 007 784 | 0,31% | Acciones |
| Korea Investment CORP | $64 394 509 | 1 003 186 | 0,31% | Acciones |
| Walleye Trading LLC | $63 084 520 | 982 778 | 0,31% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $61 600 511 | 959 659 | 0,30% | Acciones |
| National Pension Service | $60 317 674 | 939 674 | 0,29% | Acciones |
| JANE STREET GROUP, LLC | $58 470 671 | 910 900 | 0,28% | Opción de venta |
| CITADEL ADVISORS LLC | $57 584 849 | 897 100 | 0,28% | Opción de venta |
| Vinva Investment Management Ltd | $57 411 190 | 885 450 | 0,28% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $54 527 351 | 849 468 | 0,26% | Acciones |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $53 459 229 | 832 828 | 0,26% | Acciones |
| BANK OF NOVA SCOTIA | $53 046 262 | 826 395 | 0,26% | Acciones |
| California Public Employees Retirement System | $52 789 535 | 822 395 | 0,26% | Acciones |
| Gotham Asset Management, LLC | $51 174 579 | 797 236 | 0,25% | Acciones |
| Pine Valley Investments Ltd Liability Co | $49 047 579 | 764 100 | 0,24% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $48 416 284 | 754 265 | 0,23% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $46 947 683 | 730 827 | 0,23% | Acciones |
| Cresset Asset Management, LLC | $46 069 740 | 717 709 | 0,22% | Acciones |
| Walleye Trading LLC | $45 581 319 | 710 100 | 0,22% | Opción de venta |
| PRUDENTIAL FINANCIAL INC | $44 480 846 | 692 956 | 0,22% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $44 054 239 | 686 310 | 0,21% | Acciones |
| Point72 Asset Management, L.P. | $43 807 685 | 682 469 | 0,21% | Acciones |
| CAMBIAR INVESTORS LLC | $43 472 742 | 677 251 | 0,21% | Acciones |
| Kopernik Global Investors, LLC | $41 512 700 | 646 716 | 0,20% | Acciones |
| D. E. Shaw & Co., Inc. | $41 248 494 | 642 600 | 0,20% | Opción de venta |
| BARCLAYS PLC | $40 106 039 | 624 802 | 0,19% | Acciones |
| Alberta Investment Management Corp | $38 514 000 | 600 000 | 0,19% | Acciones |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $37 494 278 | 584 114 | 0,18% | Acciones |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $37 459 914 | 618 349 | 0,18% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $36 941 345 | 575 500 | 0,18% | Opción de compra |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $36 392 328 | 566 947 | 0,18% | Acciones |
| Pictet Asset Management Holding SA | $35 261 300 | 549 327 | 0,17% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $33 902 270 | 528 155 | 0,16% | Acciones |
| VANGUARD GROUP INC | $33 224 057 | 807 389 | 0,16% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $30 879 877 | 943 185 | 0,15% | Acciones |
| MACKENZIE FINANCIAL CORP | $30 726 084 | 478 674 | 0,15% | Acciones |
| IMC-Chicago, LLC | $30 548 920 | 475 914 | 0,15% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $30 455 395 | 474 457 | 0,15% | Acciones |
| Polar Capital Holdings Plc | $30 274 251 | 471 635 | 0,15% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $29 598 153 | 450 299 | 0,14% | Acciones |
Informantes de la empresa 77 insiders · 48 directivos · 30 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Sarah London | Chief Executive Officer | 15 de marzo de 2026 F | 1 188 831 | 0 | 0 | $0 |
| David P Thomas | CEO, Markets and Medicaid | 15 de diciembre de 2023 F | 132 941 | 0 | 0 | $0 |
| NEIDORFF MICHAEL F | Chairman & CEO | 15 de diciembre de 2021 A | 6 517 610 | 0 | 0 | $0 |
| Andrew Lynn Asher | Chief Financial Officer | 15 de marzo de 2026 F | 747 989 | 0 | 0 | $0 |
| William Scheffel | Exec VP, CFO & Treasurer | 1 de marzo de 2016 F | 138 362 | 0 | 0 | $0 |
| Michael A Carson | Group President, Medicare&Spec | 29 de mayo de 2026 I | — | 0 | 0 | $0 |
| Kenneth J Fasola | President | 4 de julio de 2024 F | 286 066 | 0 | 0 | $0 |
| Susan Raye Smith | Chief Operating Officer | 15 de junio de 2026 F | 212 237 | 0 | 0 | $0 |
| James E Murray | EVP, Chief Operating Officer | 23 de junio de 2023 A | 202 853 | 0 | 0 | $0 |
| Tanya M Mcnally | Chief People Officer | 15 de abril de 2026 F | 127 258 | 0 | 0 | $0 |
| Katie Casso | Corporate Controller & CAO | 15 de marzo de 2026 F | 109 776 | 0 | 0 | $0 |
| Christopher Koster | Secretary & General Counsel | 15 de marzo de 2026 F | 352 836 | 0 | 0 | $0 |
| Colin A Toney | EVP, Mergers & Acquisitions | 16 de septiembre de 2022 A | 52 123 | 0 | 0 | $0 |
| Mark J Brooks | EVP, Chief Information Officer | 16 de septiembre de 2022 A | 153 755 | 0 | 0 | $0 |
| Shannon Bagley | EVP, Chief Admin. Officer | 16 de agosto de 2022 F | 116 705 | 0 | 0 | $0 |
| Brandy Burkhalter | EVP | 24 de marzo de 2022 F | 350 475 | 0 | 0 | $0 |
| Jesse N Hunter | EVP, M&A & Chief Strategy Ofcr | 11 de junio de 2021 S | 411 792 | 0 | 0 | $0 |
| Jeffrey A. Schwaneke | EVP, HealthCare Enterprises | 7 de mayo de 2021 S | 454 549 | 0 | 0 | $0 |
| Christopher R Isaak | SVP, Corporate Controller, CAO | 15 de diciembre de 2020 F | 13 630 | 0 | 0 | $0 |
| Keith H Williamson | EVP, Secr. & General Counsel | 4 de febrero de 2020 F | 174 049 | 0 | 0 | $0 |
| Christopher D Bowers | EVP, Markets | 22 de julio de 2019 A | 131 492 | 0 | 0 | $0 |
| Cynthia J Brinkley | EVP, Chief Admin/Markets Offcr | 5 de febrero de 2019 F | 300 582 | 0 | 0 | $0 |
| Kenneth Rone Baldwin | EVP, Markets | 15 de diciembre de 2016 F | 92 712 | 0 | 0 | $0 |
| Carol Goldman | Exec VP Chief Admin Officer | 15 de diciembre de 2016 F | 70 876 | 0 | 0 | $0 |
| Donald G Imholz | EVP, Operations and CIO | 11 de diciembre de 2015 G | 151 599 | 0 | 0 | $0 |
| David C Minifie | CMO, EVP Corporate Strategy | 3 de febrero de 2015 F | 24 031 | 0 | 0 | $0 |
| Robert T Hitchcock | EVP Health Plans | 3 de febrero de 2015 F | 26 415 | 0 | 0 | $0 |
| Edmund E Kroll | SVP Fin & Investor Relations | 3 de febrero de 2015 F | 46 279 | 0 | 0 | $0 |
| HARROLD JASON M | EVP, Specialty Comp. Bus. Unit | 3 de febrero de 2015 F | 44 329 | 0 | 0 | $0 |
| Karen Bedell | SVP Business Liaison | 14 de diciembre de 2012 F | 46 819 | 0 | 0 | $0 |
| Mary V Mason | SVP & Chief Medical Officer | 14 de diciembre de 2012 F | 38 974 | 0 | 0 | $0 |
| Mark W Eggert | Executive VP, Health Plans | 14 de febrero de 2012 M | 103 712 | 0 | 0 | $0 |
| Antonette Simonetti | SVP, Public Affairs | 14 de diciembre de 2010 F | 13 377 | 0 | 0 | $0 |
| Frederick J Manning | Executive Vice President | 14 de diciembre de 2010 F | 20 579 | 0 | 0 | $0 |
| Cary Hobbs | SVP, Bus Mgmt & Integration | 16 de diciembre de 2009 M | 20 768 | 0 | 0 | $0 |
| Eric Slusser | Executive VP of Internat'l Dev | 16 de octubre de 2009 A | 51 754 | 0 | 0 | $0 |
| Patti Darnley | Sr. VP of Operations | 14 de diciembre de 2007 A | 14 188 | 0 | 0 | $0 |
| Marie J Glancy | SVP, Oper Svcs & Reg Affairs | 14 de diciembre de 2007 A | 12 362 | 0 | 0 | $0 |
| Per J Brodin | SVP, Chief Acctg Officer | 12 de diciembre de 2007 A | 13 337 | 0 | 0 | $0 |
| Glendon A Schuster | Senior VP and CIO | 12 de diciembre de 2006 A | — | 0 | 0 | $0 |
| Lisa M Wilson | Sr. VP Investor Relations | 12 de diciembre de 2006 A | 18 400 | 0 | 0 | $0 |
| Karey L Witty | SVP, Health Plan Business Unit | 12 de diciembre de 2006 A | 57 500 | 0 | 0 | $0 |
| Joseph P Drozda JR | Sr. VP & Chief Medical Officer | 12 de diciembre de 2006 A | 32 181 | 0 | 0 | $0 |
| James D Donovan JR | Senior VP Health Plans | 13 de diciembre de 2005 A | 3 219 | 0 | 0 | $0 |
| Brian G Spanel | Sr Vice President, Development | 24 de junio de 2005 M | 186 446 | 0 | 0 | $0 |
| Dan Paquin | Sr. VP New Plan Implementation | 10 de febrero de 2005 M | 0 | 0 | 0 | $0 |
| John Tadich | Senior VP, Specialty Companies | 1 de diciembre de 2004 M | 0 | 0 | 0 | $0 |
| Catherine M Halverson | Senior VP Business Development | 16 de enero de 2004 | 0 | 0 | 0 | $0 |
| Paul J Diaz | Consejero | 28 de julio de 2026 A | 2 771 | 0 | 0 | $0 |
| Lauren M Tyler | Consejero | 17 de julio de 2026 A | 3 216 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 186 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IHF · iShares Trust | 4,19% | 807 594 SH | 8 de agosto de 2026 | Diario |
| CAMX · ADVISORS' INNER CIRCLE FUND | 3,57% | 44 000 NS | 30 de abril de 2026 | N-PORT |
| SMRI · EA Series Trust | 3,05% | 307 327 NS | 30 de abril de 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,65% | 686 794 SH | 8 de agosto de 2026 | Diario |
| SRHQ · Elevation Series Trust | 1,96% | 70 588 NS | 30 de abril de 2026 | N-PORT |
| GKAT · Advisors Series Trust | 1,93% | 87 905 NS | 31 de marzo de 2026 | N-PORT |
| RUNN · Strategic Trust | 1,87% | 108 380 NS | 31 de mayo de 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,82% | 68 233 SH | 8 de agosto de 2026 | Diario |
| KAT · Advisors Series Trust | 1,68% | 345 595 NS | 31 de marzo de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,52% | 181 368 SH | 8 de agosto de 2026 | Diario |
| EPMB · Harbor ETF Trust | 1,51% | 1 264 NS | 30 de abril de 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,40% | 1 157 NS | 30 de abril de 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,32% | 2 739 NS | 30 de abril de 2026 | N-PORT |
| EPSB · Harbor ETF Trust | 1,29% | 1 122 NS | 30 de abril de 2026 | N-PORT |
| ABCS · EA Series Trust | 1,12% | 2 127 NS | 29 de mayo de 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 1,04% | 30 046 000 | 8 de agosto de 2026 | Diario |
| AVMV · AMERICAN CENTURY ETF TRUST | 1,01% | 105 126 NS | 31 de mayo de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,97% | 1 475 110 SH | 8 de agosto de 2026 | Diario |
| RILA · Spinnaker ETF Series | 0,92% | 7 203 NS | 30 de abril de 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,75% | 856 NS | 31 de mayo de 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,75% | 22 285 000 | 8 de agosto de 2026 | Diario |
| WLDR · Two Roads Shared Trust | 0,74% | 9 894 NS | 30 de abril de 2026 | N-PORT |
| ITAN · EA Series Trust | 0,66% | 9 949 NS | 29 de mayo de 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0,65% | 149 910 SH | 8 de agosto de 2026 | Diario |
| CLSE · Trust for Professional Managers | 0,64% | 66 218 NS | 31 de mayo de 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,63% | 90 872 NS | 30 de abril de 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,62% | 139 637 NS | 30 de abril de 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,53% | 3 779 NS | 30 de abril de 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,52% | 1 263 251 NS | 31 de mayo de 2026 | N-PORT |
| IYH · iShares Trust | 0,51% | 295 112 SH | 8 de agosto de 2026 | Diario |
| VLUE · iShares Trust | 0,51% | 742 494 SH | 8 de agosto de 2026 | Diario |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,48% | 18 134 000 | 8 de agosto de 2026 | Diario |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0,48% | 1 515 000 PA | 8 de agosto de 2026 | Diario |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,48% | 819 NS | 31 de mayo de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,47% | 1 478 248 SH | 8 de agosto de 2026 | Diario |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,44% | 942 740 NS | 31 de mayo de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,43% | 62 007 SH | 8 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,43% | 226 652 NS | 30 de abril de 2026 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0,43% | 1 819 403 NS | 31 de mayo de 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0,41% | 173 542 NS | 30 de abril de 2026 | N-PORT |
| RXL · ProShares Trust | 0,40% | 4 871 NS | 31 de mayo de 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,40% | 611 391 SH | 8 de agosto de 2026 | Diario |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,40% | 27 252 NS | 31 de mayo de 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,40% | 21 013 NS | 30 de abril de 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,39% | 85 952 NS | 31 de mayo de 2026 | N-PORT |
| ESMV · iShares Trust | 0,38% | 471 SH | 8 de agosto de 2026 | Diario |
| CGGO · Capital Group Global Growth Equity … | 0,38% | 728 871 NS | 31 de mayo de 2026 | N-PORT |
| IXJ · iShares Trust | 0,38% | 246 114 SH | 8 de agosto de 2026 | Diario |
| COPY · RBB Fund Trust | 0,36% | 21 043 NS | 31 de mayo de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,36% | 9 315 NS | 30 de abril de 2026 | N-PORT |